Conversely, major histocompatibility complex (MHC) class I molecules (HLA-A, HLA-B, HLA-C) were progressively downregulated, a common immune evasive strategy by cancer cells to thwart immune detection and clearance30. This evidence concerns the gene HLA-B and cancer.